Engineering and Development

ZUSDURI™ Clinical Review Published in Reviews in Urology™ Highlights Durable Efficacy and Manageable Safety Profile in Recurrent Low-Grade, Intermediate-Risk Non–Muscle Invasive Bladder Cancer

UroGen Pharma announces publication of development program for ZUSDURI

J&J wins US FDA approval of Inlexzo for bladder cancer

UroGen Pharma Executives Sell Shares

Associate Director, Quality and Compliance, Clinical Quality

UroGen Pharma is a biotech company focused on developing innovative treatments for urologic cancers. The Associate Director, Clinical Quality is responsible for managing the quality aspects of clinical development, ensuring compliance with GCP regulations and overseeing clinical activities conducted by outsourced partners.

Sign up with Google

Sign in with Google